%0 Journal Article
%T The role of histone deacetylases in inflammatory respiratory diseases: an update.
%A Pan S
%A Wang X
%A Jiao J
%A Zhang L
%J Expert Rev Clin Immunol
%V 0
%N 0
%D 2024 Jun 4
%M 38823008
%F 5.124
%R 10.1080/1744666X.2024.2363803
%X <B>UNASSIGNED: </B>Histone deacetylases (HDACs) catalyze the removal of acetyl groups from lysine residues of histones and other proteins, generally leading to a closed chromosomal configuration and transcriptional repression. Different HDACs have distinct substrate specificities and functions in different biological processes. Accumulating evidence indicates that HDACs play a key role in the pathogenesis of multiple respiratory diseases.<BR><B>UNASSIGNED: </B>After an extensive search of the PubMed database, Web of Science and ClinicalTrials.gov, covering the period from 1992 to 2024, this review summarizes recent advances in understanding the role of HDACs in inflammatory respiratory diseases, including allergic rhinitis (AR), chronic rhinosinusitis (CRS), asthma and chronic obstructive pulmonary disease (COPD). We also examine recent progress on the efficacy and potential use of histone deacetylase inhibitors (HDACi) for the treatment of these diseases.<BR><B>UNASSIGNED: </B>Available data indicate that HDACs play an important role in the development of common inflammatory respiratory diseases, and HDACi have shown promise as treatments for these diseases. However, the exact roles and underlying mechanisms of specific HDACs in disease pathogenesis require further study. Additional work is necessary to develop novel potent HDACi with high isoform selectivity.